US Senate Committee on Health, Education, Labor, & Pensions

Full Committee Hearing - Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak


Thursday, November 15 2012, 9:45 AM


106 Dirksen Senate Office Building

Witnessesreturn to top

Panel I

  • Dr. Beth Bell , Director, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
  • Dr. Peggy Hamburg , Commissioner, Food and Drug Administration, Washington, DC
  • Dr. Lauren Smith , Interim Commissioner, Department of Public Health, Boston, MA

Panel II

  • Barry Cadden , Owner and Director of Pharmacy, New England Compounding Center, Framingham, MA

Panel III

  • Dr. Marion Kainer , Director, Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health, Nashville, TN
  • David G. Miller , Executive Vice President and CEO, International Academy of Compounding Pharmacy, Missouri City, TX
  • Dr. Kasey K. Thompson , Vice President, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD